As of Feb 27
| -0.0692 / -8.05%|
The 1 analysts offering 12-month price forecasts for Opexa Therapeutics Inc have a median target of 4.00, with a high estimate of 4.00 and a low estimate of 4.00. The median estimate represents a +406.33% increase from the last price of 0.79.
There are no recommendations available.
Move your mouse over a quarter or year to see how estimates have changed over time.